Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Koninklijke Philips (PHG) EPS (Weighted Average and Diluted) (2017 - 2024)

Koninklijke Philips' quarterly EPS (Weighted Average and Diluted) came in at -$1086.4 in Q1 2024, down 52.66% year-on-year from -$2294.8 in Q2 2023, and down 121.42% quarter-over-quarter from -$490.63 in Q4 2023.

Koninklijke Philips has reported EPS (Weighted Average and Diluted) for 8 years, with the latest figure at -$1086.4 in Q1 2024.

  • For the quarter ending Q1 2024, EPS (Weighted Average and Diluted) fell 52.66% year-over-year to -$1086.4; the trailing twelve-month figure through Mar 2024 stood at -$2037.4 (up 19.67% YoY), and the FY2025 full-year result was $1.08, up 235.08% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2024 stood at -$1086.4, down from -$490.63 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $1181.6 in Q4 2020, with the low at -$1520.5 in Q3 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$155.89, with a median of -$115.29 recorded in 2022.
  • Year-over-year, EPS (Weighted Average and Diluted) soared 145.78% in 2020 and slumped 396.4% in 2022.
  • Tracing PHG's EPS (Weighted Average and Diluted) over 5 years: stood at $1181.6 in 2020, then sank by 85.96% to $165.88 in 2021, then sank by 169.5% to -$115.29 in 2022, then plunged by 325.57% to -$490.63 in 2023, then slumped by 121.42% to -$1086.4 in 2024.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$1086.4 (Q1 2024), -$490.63 (Q4 2023), and -$538.85 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 1.22

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 -1,086.36
Dec 31, 2023 -490.63
Sep 30, 2023 -538.85
Jun 30, 2023 78.40
Mar 31, 2023 -711.63
Dec 31, 2022 -115.29
Sep 30, 2022 -1,520.48
Jun 30, 2022 -188.87
Mar 31, 2022 -170.60
Dec 31, 2021 165.88
Sep 30, 2021 512.99
Mar 31, 2021 -41.01
Dec 31, 2020 1,181.56
Sep 30, 2020 568.85
Mar 31, 2020 17.66
Dec 31, 2019 608.79
Sep 30, 2019 231.45
Jun 30, 2019 287.65
Mar 31, 2019 195.50
Dec 31, 2018 1,487.24
Sep 30, 2018 355.92
Jun 30, 2018 220.79
Mar 31, 2018 116.71
Dec 31, 2017 549.86
Sep 30, 2017 646.28
Jun 30, 2017 134.15
Mar 31, 2017 -50.27